•
Dec 31, 2023

AN2 Therapeutics Q4 2023 Earnings Report

Total Revenue
$0
EPS
-$0.57
Previous year: -$0.61
-6.6%
Gross Profit
$0
Cash and Equivalents
$107M
Previous year: $27.2M
+294.2%
Total Assets
$139M
Previous year: $103M
+35.3%

AN2 Therapeutics

AN2 Therapeutics